A citation-based method for searching scientific literature

Joan L Kramer, Isela A Velazquez, Bingshu E Chen, Philip S Rosenberg, Jeffery P Struewing, Mark H Greene. J Clin Oncol 2005
Times Cited: 96



Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes, Charmaine Kim-Sing, Teresa Wagner, Nadine Tung, Fergus Couch, Dominique Stoppa-Lyonnet, Peter Ainsworth, Mary Daly, Babara Pasini, Ruth Gershoni-Baruch, Charis Eng, Olufunmilayo I Olopade, Jane McLennan, Beth Karlan, Jeffrey Weitzel, Ping Sun, Steven A Narod. JAMA 2006
Times Cited: 390




List of shared articles



Times cited





The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
Lynn C Hartmann, Noralane M Lindor. N Engl J Med 2016
148

Local approaches to hereditary breast cancer.
B T Cooper, J O Murphy, V Sacchini, S C Formenti. Ann Oncol 2013
4

Alternatives to risk-reducing surgery for ovarian cancer.
A Gadducci, C Sergiampietri, R Tana. Ann Oncol 2013
13

New insights into breast cancer genetics and impact on patient management.
Diana S Rosman, Virginia Kaklamani, Boris Pasche. Curr Treat Options Oncol 2007
15

Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.
Mohamed Salhab, Selina Bismohun, Kefah Mokbel. BMC Womens Health 2010
41

Management of hereditary breast and ovarian cancer.
Hideko Yamauchi, Junko Takei. Int J Clin Oncol 2018
11

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.
J V Cohen, L Chiel, L Boghossian, M Jones, J E Stopfer, J Powers, T R Rebbeck, K L Nathanson, S M Domchek. Fam Cancer 2012
36


Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
George U Eleje, Ahizechukwu C Eke, Ifeanyichukwu U Ezebialu, Joseph I Ikechebelu, Emmanuel O Ugwu, Onyinye O Okonkwo. Cochrane Database Syst Rev 2018
30


Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
153


Online tool to guide decisions for BRCA1/2 mutation carriers.
Allison W Kurian, Diego F Munoz, Peter Rust, Elizabeth A Schackmann, Michael Smith, Lauren Clarke, Meredith A Mills, Sylvia K Plevritis. J Clin Oncol 2012
57

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
836

A comprehensive approach to the identification and management of the BRCA patient.
Christine Garcia, C Bethan Powell. Obstet Gynecol Surv 2015
3



Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.
Angiolo Gadducci, Nicoletta Biglia, Stefania Cosio, Piero Sismondi, Andrea Riccardo Genazzani. Gynecol Endocrinol 2010
18

SGO White Paper on ovarian cancer: etiology, screening and surveillance.
John O Schorge, Susan C Modesitt, Robert L Coleman, David E Cohn, Noah D Kauff, Linda R Duska, Thomas J Herzog. Gynecol Oncol 2010
94

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Dimitrios H Roukos, Evangelos Briasoulis. Nat Clin Pract Oncol 2007
90

Clinical management of hereditary breast cancer syndromes.
Amy S Clark, Susan M Domchek. J Mammary Gland Biol Neoplasia 2011
30

Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.
P Shah, M Rosen, J Stopfer, J Siegfried, R Kaltman, B Mason, K Armstrong, K L Nathanson, M Schnall, S M Domchek. Breast Cancer Res Treat 2009
22

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.
Kerstin Rhiem, Dolores Foth, Barbara Wappenschmidt, Heidrun Gevensleben, Reinhard B├╝ttner, Uwe Ulrich, Rita K Schmutzler. Arch Gynecol Obstet 2011
27

The clinical management of BRCA1 and BRCA2 mutation carriers.
Anthony P Gulati, Susan M Domchek. Curr Oncol Rep 2008
11


Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
353

Prophylactic oophorectomy in women at increased cancer risk.
Susan M Domchek, Timothy R Rebbeck. Curr Opin Obstet Gynecol 2007
41